Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialLennart Hansson, S. Westerling, Alberto Zanchetti et al.|The Lancet|1998Cited by 5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololBjörn Dahlöf, Hans Wedel, Richard B. Devereux et al.|The Lancet|2002Cited by 5.4k
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololLars Lindholm, Steven Snapinn, Hans Ibsen et al.|The Lancet|2002Cited by 1.6k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysisKazem Rahimi, Barry R. Davis, Takayoshi Ohkubo et al.|The Lancet|2021Cited by 997
Mild High-Renin Essential HypertensionMurray Esler, Vincent DeQuattro, Stevo Julius et al.|New England Journal of Medicine|1977Cited by 536